本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ADC Therapeutics SA

1.45
+0.01501.05%
成交量:15.25万
成交额:21.73万
市值:1.43亿
市盈率:-0.89
高:1.48
开:1.43
低:1.37
收:1.43
数据加载中...
2021/03/18

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/09/14

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/05/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/14

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/12

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/12

SEC问询函

CORRESP [Cover] - Correspondence